center for biotechnology home
 

Developing a comprehensive workforce development initiative.

home > education+workforce development > undergraduate level programs > ibrp > a. dilmanian
Celebrating 20 Years of Leadership and Economic Growth
   
  2004 5-Year Report » High Res PDF | Low Res PDF  

Interdisciplinary Biomedical Research Program (IBRP)

 
   
 

Avraham Dilmanian, Ph.D.
Scientist, Medical Department, Brookhaven National Laboratory (BNL), Upton, New York; Associate Professor of Radiology and Biomedical Engineering, SUNY Stony Brook.
Funding through the National Institute of Neurological Disorders and Stroke.

Our research program is focused on the study of the effects of very thin (less than 300 micrometer in width) planes of x rays (microplanar beams, microbeams) on the central nervous system (CNS). It has been shown that single microbeams, and arrays of parallel microbeams, are very well tolerated by the CNS at doses reaching several hundred Grays. This effect has been attributed in part to the survival of the endothelial cells (the cells that line capillary blood vessels) and progenitor glial cells residing outside the direct microbeam paths, which then replace their lethally injured neighbors through different mechanisms. As a result, the capillary blood vessels repair themselves from the resulting damage, and the glial system (oligodendrocytes and astrocytes) is also regenerated. Another remarkable effect of microbeams is that they preferentially damage malignant tumors, even when administered from a single direction, at doses that are tolerated by the surrounding normal tissue. This effect has been attributed to the failure of the capillary blood vessels to recover from the microbeams’ assault because of their abnormal endothelial cells and vessel walls.


Figure 1. Loss of oligodendrocytes (APC+), Astrocytes (GFAP+), and other cells (Hoechst+) in white matter of the rat brain one week after exposure to a 270-µm wide, 650 Gy microbeam. Later time points showed repopulation of both the oligodendrocytes and astrocytes (work in collaboration with Dr. John W. McDonald of Departments of Neurology, Neurological Surgery, and Anatomy and Neurobiology, Washington University, St. Louis, Missouri).

Besides the potential of microbeams to develop as a new method of radiation therapy, the above-mentioned effects of microbeams on the normal CNS make them a powerful tool to study the recovery of the system form death of glial cells and destruction of myelin cause by single microbeams of very high dose. The methods that have been used in the past to kill oligodendrocytes and destroy myelin severely damage the CNS. However, rat brain and spinal cord irradiated with up to 750 Gy microbeams recover with no apparent vascular damage (i.e., the tissue’s infrastructure does not collapse), and very little damage to axons. Fig. 1 shows response of a rat brain to microbeams two weeks after irradiation.

The animal models currently used are the rat brain tumor 9LGS for the cancer research, and the rat brain and the spinal cord for the study of the glial system and the demyelination/remyelination processes. Several undergraduate students are currently participating in the microbeam project. The tasks include a) tumor inoculation, b) assistance with animal irradiations at the X17B1 superconducting wiggler beamline of the National Synchrotron Light Source, BNL, c) follow up of the irradiated rats using weighing and the behavioral test “Rotor-rod” that measures the rat’s sensorimotor competency, d) tissue perfusion and dissection, and e) data analysis. The technical task is to master the Monte Carlo simulation code EGS4, and use it to calculate the spatial distribution of the radiation absorbed dose in the tissues from the microbeam(s).

Contact Information
email: dilmanian@bnl.gov

 

 

back to top
 
 
    ny star logo, career and biotech businesses in nystony brook university  - top rated biotechnology school / program